Abstract
Focal sclerosing glomerulopathy and especially focal segmental glomerulosclerosis (FSGS) have been recognized as a distinct clinical entity, however, there still exist controversies in terms of prognostic risk factors of progression and optimal mode of treatment. A total of 32 patients (2 with focal global sclerosis; FGS, the remainder with FSGS) were followed up for a mean period of 82 months (3–240 months). Fourteen presented with nephrotic syndrome and 18 had proteinuria with or without hypertension. Thirteen patients, all of whom except 1 were nephrotic, received steroid treatment with or without other immunosuppressive agents (cyclophosphamide/cyclosporin A/azathioprine). Three of the steroid-treated remained stable in complete remission; 5 nephrotic non-responders had renal death. The mean slope of 1/creatinine versus time for steroid-treated and non-treated groups was −0.23 and −0.043, respectively (p=0.04), suggesting that nephrotic range proteinuria might be prognostically important. However, for the population of FSGS/FGS as a whole, only the initial serum creatinine predicted renal survival (p=0.001 by Cox's regression model). Hypertension and hypercholesterolaemia were not important variables by themselves. Nevertheless, we found that the 9 patients treated with antihyperlipidaemics (gemfibrozil/probucol/cholestyramine/maxEPA) fared better, mean slope being −0.023 versus −0.103 for non-treated, though not reaching statistical significance (p=0.96). Controlled prospective study involving a larger number of patients might be worthwhile.
Similar content being viewed by others
References
Chan, M. K., Yin, P. D., Chan, K. W.: Primary glomerulonephritis in Hong Kong.Int. Urol. Nephrol., 20, 413 (1988).
Velosa, J. A., Donadio, J. V., Holley, K. E.: Focal sclerosing glomerulonephropathy.Mayo Clin. Proc., 50, 121 (1975).
Korbet, S. M., Schwartz, M. M., Lewis, E. J.: The prognosis of focal segmental glomerular sclerosis of adulthood.Medicine, 65, 304 (1986).
Pei, Y., Cattran, D., Delmore, T., Katz, A., Lang, A., Lance, P.: Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis.Amer. J. Med., 82, 938 (1987).
Beaufils, H., Alphonse, J. C., Geudon, J., Legrain, M.: Focal glomerulosclerosis: natural history and treatment.Nephron, 21, 75 (1978).
Cameron, J. S., Turner, D. R., Ogg, C. S., Chantler, C., Williams, D. G.: The long-term prognosis of patients with focal segmental glomerulosclerosis.Clin. Nephrol., 10, 213 (1978).
Brown, C. B., Cameron, S., Turner, D. R., Chantler, C., Ogg, C. S., Williams, D. G., Bewick, M.: Focal segmental glomerulosclerosis with rapid decline in renal function (“malignant FSGS”).Clin. Nephrol., 10, 51 (1978).
Habib, R.: Focal glomerular sclerosis (Editorial).Kidney Int., 4, 355 (1973).
Kaplan, C., Pasternack, B., Shah, H., Gallo, G.: Age-related incidence of sclerotic glomeruli in human kidneys.Amer. J. Pathol., 80, 227 (1975).
Pabico, R. C., Cala, A. R., McKenna, A., Freeman, R. B.: The effects of massive proteinuria on renal tubular functions in patients with glomerulonephritis (Abstract).Kidney Int., 10, 507 (1976).
Saint-Hillier, Y., Morel-Maroger, L., Woodrow, D., Richet, G.: Focal and seg,ental hyalinosis.Adv. Nephrol., 5, 67 (1975).
Wingen, A. M., Muller-Wiefel, D. E., Scharer, K.: Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.Clin. Nephrol., 23, 35 (1985).
Tejani, A.: Morphological transition in minimal change nephrotic syndrome.Nephron, 37, 157 (1985).
Chan, P. C. K., Chan, K. W., Cheng, I. K. P., Chan, M. K.: A patient with focal segmental glomerulosclerosis and acute renal failure due to crescentic membranoproliferative glomerulonephritis.Nephron (in press).
Meyrier, A., Simon, P.: Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.Adv. Nephrol. 17, 127 (1988).
Kincaid-Smith, P., Yeung, C. K.: Focal and segmental proliferative glomerulonephritis, focal and segmental hyalinosis and sclerosis, and focal sclerosis in the adult. In: Kincaid-Smith, P., Matthew, T. H., Becker, E. C. (eds.) Glomerulonephritis. John Wiley, New York 1973, pp. 231–243.
Kasiske, B. L., Cleary, M. P., O'Donnell, M. P., Keane, W. F.: Effects of genetic obesity on renal structure and function in the Zucker rat.J. Lab. Clin. Med., 106, 598 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chan, P.C.K., Chan, K.W., Cheng, I.K.P. et al. Focal sclerosing glomerulopathy risk factors of progression and optimal mode of treatment. International Urology and Nephrology 23, 619–629 (1991). https://doi.org/10.1007/BF02549856
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549856